World Leaders in Laser Technology

16,000+ Devices in the Market and 18 FDA-Clearances

91% Customer Satisfaction

Our clients say it all: best products, service, training, and support.

Highest Quality Products

State-of-the-art technology with best possible certifications (FDA Level One 510k).

Fast ROI

Make your investment back in months. We’ll help you at every stage.

With over 25 years of experience, 16,000+ devices in the market, and 18 FDA-clearances, Erchonia® Corporation are world leaders in non-thermal laser technologies for pain management, fat loss, cellulite reduction, nail fungus removal, and more.

Based in the UK, Erchonia Lasers Ltd are a subsidiary organisation. We provide personal support to companies in Europe, Middle East, and Africa, and we work closely with our mother company to give our customers the best possible products, training, and service.

About Erchonia® Corporation

Erchonia® Corp was founded in 1996 by Mr Steve Shanks and Mr Kevin Tucek, and are a Medical Device Developer and Manufacturer of Non-Thermal Low-Level Lasers. 

Erchonia’s lasers are an advanced delivery system transporting photonic energy via electromagnetic energy transfer into the body through a true laser beam (monochromatic, collimated, and coherent). Our lasers are used to treat a wide variety of conditions, including reducing body fat, treating the appearance of cellulite, eliminating pain, accelerating healing, treating acne, treating foot fungus, and much more. 

Erchonia® were the first Low-Level Laser in the world to gain US FDA market clearance in 2002, and we now own 18 of the 21 FDA clearances given to Low-Level Lasers.

All Erchonia® laser systems are cut from raw materials, and all products go through a rigorous quality control process before delivery to our customers around the world.  As a company, we are 85% self-reliant in ALL facets of our organisation, and all of our products are FDA, ISO, OSHA, and MDSAP compliant.

Erchonia® Corp remain family owned and operated, so we are very much in touch with our customers on a personal level. One of the statistics we are most proud of is our 91% Customer Satisfaction Rating.

Erchonia® have over $5 million invested in research and development at any one time to make sure we keep pushing the boundaries in Low-Level Laser Therapy (LLLT).

All studies carried out to obtain US FDA-approvals are Level One (510k), so are placebo controlled, double blind, randomised, and multi-centre – the most credible certifications in the market

Our Team

Simon Ramshaw

Managing Director

Jody Granito

EMEA Office Manager

Julie Davies

Conference & Events Manager/Exec Asst to MD

Robert Sullivan

Clinical Consultant and Medical Educator – All Lasers

BSc.(Hons) Pod, MSc. Pod Surg (Edin). DSc Pod. Sc., M.Inst,ChP, FIChPA, FSSChP. HCPC Reg

Martine Silverman

Clinical Consultant, Lunula

BSc(hons) Podiatry MCPod HCPC

Quality Mission

The Erchonia® mission statement is simply “Quality Not Compromise”, and is ingrained in every aspect of our business – from an unwavering belief in the limitless potential applications of low-level lasers, down to the care and quality of the smallest component of our devices. Just pick up any Erchonia® product, feel the quality of workmanship, and see the attention to detail that can only come from Erchonia’s near-complete control of the manufacturing and assembly processes that go into each product bearing the Erchonia® name.

Success Story

  1. 1/2002

    Treatment of chronic neck and shoulder pain (red) and 08/2019 (red/violet). Treatment of chronic neck and shoulder pain.
  2. 9/2004

    Liposuction assistance and reduction of associated pain.

  3. 5/2005

    Treatment of acne.

  4. 4/2008

    Breast augmentation assistance and reduction of associated pain.

  5. 8/2010

    Circumference reduction of the waist, hips, and thighs (Zerona).

  6. 5/2012

    Non-invasive circumference reduction of the arms (Zerona arm).

  7. 5/2013

    Non-invasive body contouring of the waist, hips, and thighs (Verjú).

    Reduction in the appearance of cellulite (Verju laser system with massager).

  8. 4/2014

    The relief of chronic heel pain from plantar fasciitis (FX 635).

    10/2014

    Non-invasive body contouring of the waist, hips, and upper abdomen for BMI 30-40.

  9. 1/ 2015

    Zerona OTC – Non-invasive dermatological aesthetic treatment for the reduction of the circumference of the hips, waist, and thighs.

    5/2015

    Zerona-Z6 (6) Week Protocol – Non-invasive dermatological aesthetic treatment for the reduction of circumference of hips, waist, thighs, and upper abdomen (1 x per Week for 6 weeks).

  10. 1/ 2016

    The Lunula Laser device is indicated for use for the temporary increase of clear nail in patients with onychomycosis.

    12/2016

    Zerona OTC Overall Body Circumference Reduction. The ZERONA Z6 OTC Laser is indicated for use as a non-invasive dermatological aesthetic treatment for the reduction of body circumference.

  11. 5/2018

    FX 635 laser is indicated as an adjunct to provide relief of minor chronic low back pain of musculoskeletal origin, and is also indicated as an adjunct to reducing chronic heel pain arising from plantar fasciitis.

  12. 6/2019

    Temporary relief of chronic, nociceptive musculoskeletal pain.